Abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
Abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / abrdn Life Sciences Investors ("HQL") announced today the results of the Annual Meeting of Shareholders (the "Meeting"), held on June 25, 2024.
宾夕法尼亚州费城/ACCESSWIRE/2024年6月26日/abrdn Life Sciences Investors（“HQL”）今天公布了2024年6月25日举行的年度股东大会（“会议”）的结果。
As of the record date, April 1, 2024, HQL had outstanding 27,350,517 shares of common stock. 87.84% of outstanding common stock were voted representing a quorum.
截至创纪录的日期，即2024年4月1日，HQL已发行27,350,517股普通股。87.84％的已发行普通股被选为法定人数。
Shareholders approved the election of two Class B Trustees to the Board to serve until 2027 Annual Meeting by the following votes:
股东们通过以下投票批准选举两名B类受托人进入董事会，任期至2027年年会：
Number of Votes Cast For |
Percentage of Votes Cast For |
Number of Votes Cast Against/Withheld |
Percentage of Votes Cast Against / Withheld |
|
| Stephen Bird | 20,269,963 |
84.4% |
3,753,701 |
15.6% |
| Jeffrey Bailey | 19,670,734 |
81.9% |
4,352,930 |
18.1% |
投的选票数 |
投的选票百分比 |
反对/扣留的选票数 |
反对/拒付的选票百分比 |
|
| 斯蒂芬伯德 | 20,269,963 |
84.4% |
3,753,701 |
15.6% |
| 杰弗里·贝利 | 19,670,734 |
81.9% |
4,352,930 |
18.1% |
Shareholders opposed a shareholder proposal regarding annual terms of trustees by the following votes:
股东以以下投票反对股东关于年度受托人任期的提案：
Number of Votes Cast For |
Percentage of Votes Cast For |
Number of Votes Cast Against/Withheld |
Percentage of Votes Cast Against / Withheld |
Number of Votes |
Percentage |
6,891,241 |
41.6% |
9,133,348 |
55.1% |
533,327 |
3.3% |
投的选票数 |
投的选票百分比 |
反对/扣留的选票数 |
反对/拒付的选票百分比 |
选票数 |
百分比 |
6,891,241 |
41.6% |
9,133,348 |
55.1% |
533,327 |
3.3% |
In the United States, abrdn is the marketing name for the following affiliated, registered investment advisers: abrdn Inc., abrdn Investments Limited, abrdn Asia Limited, and abrdn ETFs Advisors LLC.
在美国，abrdn是以下附属注册投资顾问的市场名称：abrdn Inc.、abrdn Investments Limited、abrdn Asia Limited和abrdn ETFs Advisors LLC。
Closed-end funds are traded on the secondary market through one of the stock exchanges. A Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that a Fund will achieve its investment objective. Past performance does not guarantee future results.
封闭式基金通过其中一个证券交易所在二级市场上交易。基金的投资回报和本金价值将波动，因此投资者的股票价值可能高于或低于原始成本。封闭式基金的股票交易价格可能高于基金投资组合的净资产价值（NAV）（溢价）或低于（折扣）。无法保证基金会实现其投资目标。过去的表现并不能保证未来的业绩。
# # #
# #
For More Information Contact:
abrdn U.S. Closed-End Funds
Investor Relations
800-522-5465
Investor.Relations@abrdn.com
欲了解更多信息，请联系：
bardn 美国封闭式基金
投资者关系
800-522-5465
Investor.Relations@abrdn.com
SOURCE: abrdn U.S. Closed-End Funds
来源：abrdn 美国封闭式基金